• Slovenščina
  • English
  • Hrvatski

+386 1 438 16 00

  

info@rapharm.eu

raPHARM raPHARM
  • Who we are
  • What we do
    • Consulting & Services
    • Regulatory intelligence
    • Education & Training
    • International projects
  • Actual educations
  • News
  • Application form
    • Apply for consultation
    • Apply for education
  • Contact

Category: Uncategorized

Home / Uncategorized

Educational conference: PACIENT SUPPORT PROGRAM – WHAT IS ALLOWED IN THE EU AND WHAT IS NOT?

0
On 19/09/201819/10/2018By rapharmIn Current educations and trainings, Regulatory news, Uncategorized

26th November 2018 Radisson Blu Plaza Hotel Ljubljana (Slovenian language) Educational conference PACIENT SUPPORT PROGRAM – WHAT IS ALLOWED IN THE EU...

Read More

Regulatory conference ETHICS IN REGULATORY AFFAIRS FOR MEDICINAL PRODUCTS AND MEDICAL DEVICES

0
On 20/02/201821/02/2018By rapharmIn Current educations and trainings, Regulatory news, Uncategorized

25th & 26th April 2018 Radon Plaza Hotel Sarajevo (Serbo-Croatian-Bosnian-Montenegrian language) Regulatory conference ETHICS IN REGULATORY AFFAIRS FOR MEDICINAL PRODUCTS AND MEDICAL...

Read More

We invite new colleagues into raPHARM team

0
On 03/10/201723/11/2017By rapharmIn Regulatory news, Uncategorized

Due to the growing workload and the challenges ahead, we invite new colleagues to our team. Providing: Steady employment for...

Read More
  • 1
  • 2
  • 3

About raPHARM

raPHARM is a consultancy and education office specialising in pharmaceutical and medical devices regulatory affairs. The office was founded by Ms Vesna Koblar, MD. PhD., an internationally recognised expert in this area with extensive experience and knowledge.

Navigation

  • Who we are
  • What we do
  • Actual educations
  • News
  • Application form
  • Contact

Application form

  • Apply for consultation
  • Apply for education

Contact

  • raPHARM, Ltd.
  • 30 Miklošičeva Street
  • SI-1000 Ljubljana, Slovenia, EU
  • E: info@rapharm.eu
  • T: +386 1 438 16 00
© 2016 raPHARM d.o.o.